139 related articles for article (PubMed ID: 27999669)
1. The diabesity health economic crisis-the size of the crisis in a European island state following a cross-sectional study.
Cuschieri S; Vassallo J; Calleja N; Pace N; Abela J; Ali BA; Abdullah F; Zahra E; Mamo J
Arch Public Health; 2016; 74():52. PubMed ID: 27999669
[TBL] [Abstract][Full Text] [Related]
2. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of obesity in Malta.
Cuschieri S; Vassallo J; Calleja N; Camilleri R; Borg A; Bonnici G; Zhang Y; Pace N; Mamo J
Obes Sci Pract; 2016 Dec; 2(4):466-470. PubMed ID: 28090352
[TBL] [Abstract][Full Text] [Related]
4. Economic Impact of Diabetes in Africa.
Mapa-Tassou C; Katte JC; Mba Maadjhou C; Mbanya JC
Curr Diab Rep; 2019 Jan; 19(2):5. PubMed ID: 30680578
[TBL] [Abstract][Full Text] [Related]
5. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
Szybiński Z
Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
[TBL] [Abstract][Full Text] [Related]
6. Diabesity: an overview of a rising epidemic.
Farag YM; Gaballa MR
Nephrol Dial Transplant; 2011 Jan; 26(1):28-35. PubMed ID: 21045078
[TBL] [Abstract][Full Text] [Related]
7. Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050.
Png ME; Yoong J; Phan TP; Wee HL
BMC Public Health; 2016 Feb; 16():153. PubMed ID: 26880337
[TBL] [Abstract][Full Text] [Related]
8. An obesogenic island in the Mediterranean: mapping potential drivers of obesity in Malta.
Cauchi D; Rutter H; Knai C
Public Health Nutr; 2015 Dec; 18(17):3211-23. PubMed ID: 25753315
[TBL] [Abstract][Full Text] [Related]
9. The effect of age, gender, TG/HDL-C ratio and behavioral lifestyles on the metabolic syndrome in the high risk Mediterranean Island population of Malta.
Cuschieri S; Vassallo J; Calleja N; Pace N; Mamo J
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S321-S327. PubMed ID: 28283398
[TBL] [Abstract][Full Text] [Related]
10. Predictions Burden of Diabetes and Economics Cost: Contributing Risk Factors of Changing Disease Prevalence and its Pandemic Impact to Qatar.
Bener A; Al-Hamaq AO
Exp Clin Endocrinol Diabetes; 2016 Sep; 124(8):504-511. PubMed ID: 27023007
[No Abstract] [Full Text] [Related]
11. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
Wolfenstetter SB
Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
[TBL] [Abstract][Full Text] [Related]
12. The characteristics of an obesogenic small European country: results from a Malta cross-sectional study.
Cuschieri S
Perspect Public Health; 2020 Nov; 140(6):327-337. PubMed ID: 32650711
[TBL] [Abstract][Full Text] [Related]
13. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
Davis WA; Knuiman MW; Hendrie D; Davis TM
Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
[TBL] [Abstract][Full Text] [Related]
14. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
[TBL] [Abstract][Full Text] [Related]
15. The cost of obesity in Canada.
Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
[TBL] [Abstract][Full Text] [Related]
16. Getting to grips with the obesity epidemic in Europe.
Cuschieri S; Mamo J
SAGE Open Med; 2016; 4():2050312116670406. PubMed ID: 27708778
[TBL] [Abstract][Full Text] [Related]
17. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.
Bommer C; Heesemann E; Sagalova V; Manne-Goehler J; Atun R; Bärnighausen T; Vollmer S
Lancet Diabetes Endocrinol; 2017 Jun; 5(6):423-430. PubMed ID: 28456416
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the burden of diabetes in Poland].
Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
